1-12 of 12
Cristina Nanni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Imaging FDG-PET/CT Minimal Residual Disease Assessment on Outcomes and Matching with Bone Marrow Techniques in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results of the Phase II Randomized Forte Trial

Elena Zamagni, Cristina Nanni, MD, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Mattia D'Agostino, MD, Rossella Ribolla, MD, Monica Galli, Manuela Racca, MD, Renato Zambello, Elena Rivolti, MD, Domenico Albano, MD, Annibale Versari, MD, Mariella Grasso, Rossella Troia, PharmD, Antonio Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, MD, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, MD PhD, Mario Boccadoro, Michele Cavo, Pellegrino Musto, Stefania Oliva
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-137412
Published: 2020
Journal Articles

MRD Evaluation By PET/CT According to Deauville Criteria Combined with Multiparameter Flow Cytometry in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients Enrolled in the Phase II Randomized Forte Trial

Elena Zamagni, MD, Cristina Nanni, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Paola Omedé, Rossella Ribolla, MD, Monica Galli, Manuela Racca, Renato Zambello, Barbara Gamberi, MD, Domenico Albano, Annibale Versari, Mariella Grasso, Rossella Troia, Tonino Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, Prof, MD PhD, Mario Boccadoro, Michele Cavo, Stefania Oliva
Journal: Blood
Blood (2019) 134 (Supplement_1): 4321.
https://doi.org/10.1182/blood-2019-125134
Published: 2019
Journal Articles

Standardization of 18F-FDG PET/CT According to Deauville Criteria for MRD Evaluation in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Joined Analysis of Two Prospective Randomized Phase III Trials

Elena Zamagni, MD, Cristina Nanni, Luca Dozza, MSc, Thomas Carlier, Paola Tacchetti, MD PhD, Annibale Versari, Stephane Chauvie, Andrea Gallamini, MD, Michel Attal, Barbara Gamberi, MD, Denis Caillot, Francesca Patriarca, MD, Margaret Macro, Mario Boccadoro, MD, Laurent Garderet, Stefano Fanti, Aurore Perrot, Francesca Gay, MD, Pieter Sonneveld, MDPhD, Lionel Karlin, MD, Michele Cavo, MD, Caroline Bodet-Milin, Philippe Moreau, Francoise Kraeber-Bodere
Journal: Blood
Blood (2018) 132 (Supplement 1): 257.
https://doi.org/10.1182/blood-2018-99-111321
Published: 2018
Journal Articles

PET/CT Guided Biopsy for the Diagnosis of Lymphoma

Alessandro Broccoli, Cristina Nanni, Alberta Cappelli, Francesco Bacci, MD, Alessandro Gasbarrini, Lucia Zanoni, Stefano Brocchi, Sebastiano Spagnolo, Carlo Piovani, Lisa Argnani, Stefano Boriani, Elena Sabattini, Rita Golfieri, Stefano Fanti, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2857.
https://doi.org/10.1182/blood.V130.Suppl_1.2857.2857
Published: 2017
Journal Articles

Prospective Evaluation of 18F-FDG PET/CT As Predictor of Prognosis in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results from the Imaging Sus-Study of the EMN02/HO95 MM Randomized Phase III Trial

Elena Zamagni, Cristina Nanni, Paola Tacchetti, Annibale Versari, Stephane Chauvie, Lucia Pantani, Andrea Bianchi, Marco Rensi, Marilena Bellò, Ilaria Rambaldi, Andrea Gallamini, Francesca Patriarca, Carolina Terragna, Elisa Bertone, Francesca Gay, Barbara Gamberi, MD, Alessandra Larocca, MD, Beatrice A Zannetti, Mario Boccadoro, Katia Mancuso, Stefano Fanti, Pieter Sonneveld, Michele Cavo
Journal: Blood
Blood (2016) 128 (22): 992.
https://doi.org/10.1182/blood.V128.22.992.992
Published: 2016
Journal Articles

18F-Fluorothymidine Positron Emission Tomography in Patients with Suspect Lymphoma Relapse

Alessandro Broccoli, MD, Lucia Zanoni, Cristina Nanni, Giancarlo Montini, Vittorio Stefoni, Cinzia Pellegrini, Letizia Gandolfi, Cristina Fonti, Filippo Lodi, Michele Cavo, MD, Stefano Fanti, Pier Luigi Zinzani, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5009.
https://doi.org/10.1182/blood.V126.23.5009.5009
Published: 2015
Journal Articles

The Presence of FDG PET/CT Focal, Not Osteolytic, Lesion(s) Identifies a Sub-Group of Patients with Smoldering Multiple Myeloma with High-Risk of Progression into Symptomatic Disease

Elena Zamagni, MD, Cristina Nanni, MD, Francesca Gay, MD, Annalisa Pezzi, Statistician, Marilena Bellò, MD, Ilaria Rambaldi, MD, Paola Tacchetti, MD, Annamaria Brioli, MD, Lucia Pantani, MD, Valeria Magarotto, MD, Beatrice Anna Zannetti, MD, Massimo Menga, MD, Giulia Marzocchi, PhD, Carolina Terragna, PhD, Katia Mancuso, MD, Antonio Palumbo, MD, Stefano Fanti, MD, Michele Cavo, MD
Journal: Blood
Blood (2014) 124 (21): 3371.
https://doi.org/10.1182/blood.V124.21.3371.3371
Published: 2014
Journal Articles

PET/CT Is a Useful Tool For Both Refining The Definition Of Complete Response (CR) In Multiple Myeloma (MM) and Detecting Otherwise Unrevealed Progression During The Follow-Up Of The Disease: A Single Centre Experience On 282 Patients

Elena Zamagni, MD, Cristina Nanni, MD, Annalisa Pezzi, Statistics, Katia Mancuso, Paola Tacchetti, MD, Lucia Pantani, MD, Beatrice Anna Zannetti, MD, Annamaria Brioli, MD, Serena Rocchi, MD, Giulia Marzocchi, PhD, Nicoletta Testoni, BS, Carolina Terragna, PhD, Giovanni Martinelli, MD, Stefano Fanti, MD, Michele Cavo, MD
Journal: Blood
Blood (2013) 122 (21): 1936.
https://doi.org/10.1182/blood.V122.21.1936.1936
Published: 2013
Journal Articles

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation

Clinical Trials & Observations
Elena Zamagni, Francesca Patriarca, Cristina Nanni, Beatrice Zannetti, Emanuela Englaro, Annalisa Pezzi, Paola Tacchetti, Silvia Buttignol, Giulia Perrone, Annamaria Brioli, Lucia Pantani, Carolina Terragna, Francesca Carobolante, Michele Baccarani, Renato Fanin, Stefano Fanti, Michele Cavo
Journal: Blood
Blood (2011) 118 (23): 5989–5995.
https://doi.org/10.1182/blood-2011-06-361386
Published: 2011
Journal Articles

Conventionally-Defined and PET/CT-Defined Complete Response (CR) to Novel Agent-Based Induction Therapy and Autologous Stem-Cell Transplantation (ASCT) In Multiple Myeloma (MM): A Prospective Study of Clinical and Prognostic Implications

Elena Zamagni, MD, Cristina Nanni, MD, Francesca Patriarca, MD, Annalisa Pezzi, Statistician, Beatrice Anna Zannetti, MD, Paola Tacchetti, MD, Emanuela Englaro, MD, Giulia Perrone, MD, Silvia Buttignol, MD, Annamaria Brioli, MD, Lucia Pantani, MD, Francesca Carobolante, MD, Michele Baccarani, MD, Stefano Fanti, MD, Michele Cavo, MD
Journal: Blood
Blood (2011) 118 (21): 826.
https://doi.org/10.1182/blood.V118.21.826.826
Published: 2011
Journal Articles

Prognostic Relevance of 18F-FDG PET/CT In Newly Diagnosed Multiple Myeloma Patients Treated with up-Front Autologous Transplantation: A Prospective Study

Elena Zamagni, Cristina Nanni, Francesca Patriarca, Paola Tacchetti, Emanuela Englaro, Giulia Perrone, Silvia Buttignol, Annamaria Brioli, Lucia Pantani, Beatrice Anna Zannetti, Francesca Caroborante, Michele Baccarani, Stefano Fanti, Michele Cavo
Journal: Blood
Blood (2010) 116 (21): 369.
https://doi.org/10.1182/blood.V116.21.369.369
Published: 2010
Journal Articles

Role of 18f-FDG PET/CT in the Management of Multiple Myeloma.

Elena Zamagni, Cristina Nanni, Patrizia Tosi, Stefano Fanti, Delia Cangini, Paolo Castellucci, Paola Tacchetti, Giulia Perrone, Michela Ceccolini, Mohsen Farsad, Michele Baccarani, Michele Cavo
Journal: Blood
Blood (2005) 106 (11): 3492.
https://doi.org/10.1182/blood.V106.11.3492.3492
Published: 2005